| Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia DL Rolnik, D Wright, LC Poon, N O’Gorman, A Syngelaki, ... New England Journal of Medicine 377 (7), 613-622, 2017 | 2024 | 2017 |
| UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation RJM Snijders, P Noble, N Sebire, A Souka, KH Nicolaides The Lancet 352 (9125), 343-346, 1998 | 2012 | 1998 |
| Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. KH Nicolaides, G Azar, D Byrne, C Mansur, K Marks British medical journal 304 (6831), 867-869, 1992 | 1531 | 1992 |
| Progesterone and the risk of preterm birth among women with a short cervix EB Fonseca, E Celik, M Parra, M Singh, KH Nicolaides, ... Obstetrical & Gynecological Survey 62 (12), 769, 2007 | 1326 | 2007 |
| Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study RWK Chiu, R Akolekar, YWL Zheng, TY Leung, H Sun, KCA Chan, ... Bmj 342, 2011 | 1127 | 2011 |
| The International Federation of Gynecology and Obstetrics (FIGO) initiative on preeclampsia (PE): a pragmatic guide for first trimester screening and prevention LC Poon, A Shennan, JA Hyett, A Kapur, E Hadar, H Divakar, F McAuliffe, ... International journal of gynaecology and obstetrics: the official organ of …, 2019 | 1110 | 2019 |
| Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities KH Nicolaides American journal of obstetrics and gynecology 191 (1), 45-67, 2004 | 992 | 2004 |
| Screening for fetal aneuploidies at 11 to 13 weeks KH Nicolaides Prenatal diagnosis 31 (1), 7-15, 2011 | 930 | 2011 |
| Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and … R Romero, K Nicolaides, A Conde-Agudelo, A Tabor, JM O'Brien, ... American journal of obstetrics and gynecology 206 (2), 124. e1-124. e19, 2012 | 834 | 2012 |
| A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A K Spencer, V Souter, N Tul, R Snijders, KH Nicolaides Ultrasound in Obstetrics and Gynecology: The Official Journal of the …, 1999 | 810 | 1999 |
| The hidden mortality of monochorionic twin pregnancies NJ Sebire, RJM Snijders, K Hughes, W Sepulveda, KH Nicolaides BJOG: An International Journal of Obstetrics & Gynaecology 104 (10), 1203-1207, 1997 | 810 | 1997 |
| Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study S Cicero, P Curcio, A Papageorghiou, J Sonek, K Nicolaides The lancet 358 (9294), 1665-1667, 2001 | 790 | 2001 |
| The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis S Roberge, K Nicolaides, S Demers, J Hyett, N Chaillet, E Bujold American journal of obstetrics and gynecology 216 (2), 110-120. e6, 2017 | 743 | 2017 |
| Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia MD Savvidou, AD Hingorani, D Tsikas, JC Frölich, P Vallance, ... The Lancet 361 (9368), 1511-1517, 2003 | 738 | 2003 |
| Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysis MM Gil, MS Quezada, R Revello, R Akolekar, KH Nicolaides Ultrasound in obstetrics & gynecology 45 (3), 249-266, 2015 | 716 | 2015 |
| Competing risks model in early screening for preeclampsia by biophysical and biochemical markers R Akolekar, A Syngelaki, L Poon, D Wright, KH Nicolaides Fetal diagnosis and therapy 33 (1), 8-15, 2013 | 709 | 2013 |
| Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study J Hyett, M Perdu, G Sharland, R Snijders, KH Nicolaides Bmj 318 (7176), 81-85, 1999 | 707 | 1999 |
| Multicenter screening for pre‐eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation AT Papageorghiou, CKH Yu, R Bindra, G Pandis, KH Nicolaides Ultrasound in Obstetrics and Gynecology: The Official Journal of the …, 2001 | 705 | 2001 |
| Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks R Akolekar, A Syngelaki, R Sarquis, M Zvanca, KH Nicolaides Prenatal diagnosis 31 (1), 66-74, 2011 | 699 | 2011 |
| Analysis of cell‐free DNA in maternal blood in screening for aneuploidies: updated meta‐analysis MM Gil, V Accurti, B Santacruz, MN Plana, KH Nicolaides Ultrasound in Obstetrics & Gynecology 50 (3), 302-314, 2017 | 677 | 2017 |
